MedPath

Prospective randomized controlled study of Daikenchuto for postoperative dysmotility after total gastrectomy:

Phase 3
Conditions
Gastric cancer
Registration Number
JPRN-UMIN000002090
Lead Sponsor
Osaka University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients under emergent operation Patients with double cancer 2)Patients with severe or uncontrollable diseases related with heart, lung, liver, and kidney 3)Patients with previous open laparotomy (except the Appendectomy) 4)Patients with pregnancy or under lactation, patients expected to be under pregnancy, and patients wish to be pregnancy 5)Patients judged inappropriate by his or her doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement of postoperative symptoms and signs due to gastrointestinal dysmotility including postoperative ileus, abodominal pain, distansion
Secondary Outcome Measures
NameTimeMethod
Safety of Daikenchuto
© Copyright 2025. All Rights Reserved by MedPath